Skip to main content

Matinas BioPharma Holdings, Inc.

MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001582554

No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of MTNB: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8067−13
Shares39.7M37.7M−2.01M (−5.1%)
Value$41.7M$29.2M−$12.5M (−30.0%)

New holders (9)

Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to MTNB in Q2 2021
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP1,684,847$1.31M0.15%
Courage Capital Management LLC1,500,000$1.16M0.70%
JTC Employer Solutions Trusteee Ltd775,000$599.0K0.09%
Hudson Bay Capital Management LP600,000$465.0K0.01%
Arkadios Wealth Advisors350,000$271.0K0.03%
Platform Technology Partners191,160$148.0K0.06%
Two Sigma Investments, LP26,231$20.0K0.00%
Manufacturers Life Insurance Company, The18,954$15.0K0.00%
Occidental Asset Management, LLC12,000$9.00K0.00%

Sold out (22)

Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.